Logo image of CV

CAPSOVISION INC (CV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CV - US1409351079 - Common Stock

5.23 USD
-0.1 (-1.88%)
Last: 11/21/2025, 8:21:16 PM
5.23 USD
0 (0%)
After Hours: 11/21/2025, 8:21:16 PM
Fundamental Rating

2

Taking everything into account, CV scores 2 out of 10 in our fundamental rating. CV was compared to 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of CV is average, but there are quite some concerns on its profitability. CV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CV had negative earnings in the past year.
CV Yearly Net Income VS EBIT VS OCF VS FCFCV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -5M -10M -15M -20M

1.2 Ratios

CV has a Return On Assets of -208.42%. This is amonst the worse of the industry: CV underperforms 92.02% of its industry peers.
With a Return On Equity value of -428.93%, CV is not doing good in the industry: 81.91% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -208.42%
ROE -428.93%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CV Yearly ROA, ROE, ROICCV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 -50 -100

1.3 Margins

The Gross Margin of CV (54.24%) is comparable to the rest of the industry.
CV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CV Yearly Profit, Operating, Gross MarginsCV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

CV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CV has about the same amount of shares outstanding.
CV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CV Yearly Shares OutstandingCV Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M 40M
CV Yearly Total Debt VS Total AssetsCV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5M 10M 15M 20M

2.2 Solvency

CV has an Altman-Z score of 4.69. This indicates that CV is financially healthy and has little risk of bankruptcy at the moment.
CV has a better Altman-Z score (4.69) than 77.66% of its industry peers.
CV has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
CV has a Debt to Equity ratio of 0.22. This is comparable to the rest of the industry: CV outperforms 57.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 4.69
ROIC/WACCN/A
WACC8.7%
CV Yearly LT Debt VS Equity VS FCFCV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 1.85 indicates that CV should not have too much problems paying its short term obligations.
The Current ratio of CV (1.85) is worse than 67.55% of its industry peers.
CV has a Quick Ratio of 1.13. This is a normal value and indicates that CV is financially healthy and should not expect problems in meeting its short term obligations.
CV's Quick ratio of 1.13 is on the low side compared to the rest of the industry. CV is outperformed by 73.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.13
CV Yearly Current Assets VS Current LiabilitesCV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CV have decreased strongly by -76.06% in the last year.
The Revenue has grown by 20.54% in the past year. This is a very strong growth!
EPS 1Y (TTM)-76.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)20.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CV will show a very strong growth in Earnings Per Share. The EPS will grow by 25.49% on average per year.
Based on estimates for the next years, CV will show a very strong growth in Revenue. The Revenue will grow by 66.73% on average per year.
EPS Next Y-94.29%
EPS Next 2Y-1.56%
EPS Next 3Y25.49%
EPS Next 5YN/A
Revenue Next Year24.13%
Revenue Next 2Y31.54%
Revenue Next 3Y66.73%
Revenue Next 5YN/A

3.3 Evolution

CV Yearly Revenue VS EstimatesCV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
CV Yearly EPS VS EstimatesCV Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CV Price Earnings VS Forward Price EarningsCV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CV Per share dataCV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

CV's earnings are expected to grow with 25.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.56%
EPS Next 3Y25.49%

More info and screens

0

5. Dividend

5.1 Amount

CV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAPSOVISION INC

NASDAQ:CV (11/21/2025, 8:21:16 PM)

After market: 5.23 0 (0%)

5.23

-0.1 (-1.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)N/A N/A
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners17.43%
Ins Owner Change45.14%
Market Cap244.61M
Revenue(TTM)11.76M
Net Income(TTM)-19.90M
Analysts84.44
Price Target6.12 (17.02%)
Short Float %0.14%
Short Ratio0.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.09%
PT rev (3m)-9.09%
EPS NQ rev (1m)-13.64%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)-21.8%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.45%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.81
P/FCF N/A
P/OCF N/A
P/B 52.73
P/tB 52.73
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.25
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -208.42%
ROE -428.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.24%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.13
Altman-Z 4.69
F-ScoreN/A
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-94.29%
EPS Next 2Y-1.56%
EPS Next 3Y25.49%
EPS Next 5YN/A
Revenue 1Y (TTM)20.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year24.13%
Revenue Next 2Y31.54%
Revenue Next 3Y66.73%
Revenue Next 5YN/A
EBIT growth 1Y-75.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.99%
OCF growth 3YN/A
OCF growth 5YN/A

CAPSOVISION INC / CV FAQ

What is the fundamental rating for CV stock?

ChartMill assigns a fundamental rating of 2 / 10 to CV.


What is the valuation status for CV stock?

ChartMill assigns a valuation rating of 1 / 10 to CAPSOVISION INC (CV). This can be considered as Overvalued.


How profitable is CAPSOVISION INC (CV) stock?

CAPSOVISION INC (CV) has a profitability rating of 0 / 10.


How financially healthy is CAPSOVISION INC?

The financial health rating of CAPSOVISION INC (CV) is 4 / 10.